Nephrology Doctors in Beachwood, OH Accepting Medicare

3 Nephrology doctors found. Showing 1 - 3

Dr. Melkon O. Hajinazarian, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3619 Park East Dr Ste 110, Beachwood, OH 44122 Phone: 216-896-0639

Andrew E Lazar, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3619 Park East Dr Ste 110, Beachwood, OH 44122 Phone: 216-896-0639    Fax: 216-896-0663

Reddy Sreenivas Singasani, M.D Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 3600 Park East Dr Apt 247, Beachwood, OH 44122 Phone: 216-327-2616

News Archive

Update from ACADIA Pharmaceuticals regarding its Phase III program with pimavanserin

ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today provided an update on its Phase III program with pimavanserin for Parkinson's disease psychosis (PDP), which is being pursued in collaboration with Biovail Laboratories International SRL ("Biovail"), a subsidiary of Biovail Corporation.

PBS' NewHour examines health insurance for 'urban poor' in Pakistan

PBS' NewsHour special correspondent Saima Mohsin on Monday reported from Pakistan on "an innovative health insurance plan for the urban poor." In Pakistan, 99 percent of the country's low-income population does not have health insurance, and this plan, called Naya Jeevan, "hopes to change that.

Patterson Companies records 6% year-on-year sales growth in first-quarter

Patterson Companies, Inc. today reported consolidated sales of $789,579,000 for the first quarter of fiscal 2010 ended July 25, an increase of 6% from $743,859,000 in the year-earlier quarter. The strong performance of technology offerings in the dental equipment business, as well as higher sales of veterinary supplies, helped offset the impact of the weak economy on other portions of Patterson's business. Acquisitions, net of negative foreign currency adjustments, accounted for the majority of the first quarter sales growth. Net income was $45,057,000 or $0.38 per diluted share, compared to $45,964,000 or $0.39 per diluted share in the first quarter of 2009.

NogoReceptor reduces Alzheimer's plaque

Increasing the level of a protein that plays a key role in traumatic spinal cord injuries and multiple sclerosis reduces the concentration of disease-causing plaque in Alzheimer's disease, Yale School of Medicine researchers report in the Journal of Neuroscience.

Read more Medical News

› Verified 5 days ago